Dennis Gartman, founder, editor & publisher of The Gartman Letter, comments on Monsanto's decision to reject the Bayer acquisition proposal.
Bullish bets on Monsanto, with CNBC contributor Dan Nathan.
Bayer responds to Monsanto, stating "Bayer looks forward to constructive discussions." CNBC's David Faber reports.
Monsanto has left the door open with Bayer, reports CNBC's David Faber.
Monsanto is open to discussions after rejecting the takeover bid from Bayer.
The FMHR traders take their positions on four stocks making news today, including Deere upgraded at BMO.
Neil Dwane, global strategist at Allianz Global Investors, says many Bayer investors will view the deal negatively as they won't own Monsanto.
John Rountree, managing partner at Novasecta, talks about whether or not the Bayer-Monsanto merger would create more or less innovation and value.
Scott Moeller, director of the M&A Research Centre at Cass Business School, and John Rountree, from Novasecta, discuss the Bayer-Monsanto deal.
Just when you thought the dearth of M&A in Europe was here to stay, Bayer sweeps in with a $62 billion bid for U.S. giant Monsanto.
Bayer's shareholders were not given any indication that the firm would expand into the crop space, explains Sachin Shah from Albert Fried and Company.
Shares of Monsanto advanced 5 percent after German firm Bayer offered to buy the company for $62 billion in cash.
U.S. stocks closed lower Monday in low volume trade as investors awaited further indications on the timing of the Federal Reserve's next rate hike.
CNBC's David Faber reports the latest on Bayer's $62 billion offer for Monsanto.
The FMHR traders take their positions on four stocks making news today, including Bayer's bid for Monsanto and Freeport-McMoran cancelling its oil and gas business IPO.
European stocks finished mostly lower on Monday as investors digested a fall in oil prices, mixed data out of the euro zone and the prospect of a U.S. rate hike in June.
CNBC's Simon Hobbs reports on all the market moving events in Europe today, including Unicredit, Fiat Chrysler and Bayer.
New York-based boutique bank Ducera Partners will score a monster payday if $62B the Bayer-Monsanto deal goes through.
U.S. stock index futures pointed to a mixed open on Monday, as oil prices dipped and traders mulled more hints of near-term monetary policy tightening.
Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.